Geode Capital Management
APVO icon

Geode Capital Management’s Aptevo Therapeutics APVO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,526
Closed -$12.2K 4449
2025
Q1
$12.2K Buy
+10,526
New +$12.2K ﹤0.01% 4422
2024
Q4
Sell
-43,684
Closed -$7.85K 4475
2024
Q3
$7.85K Buy
43,684
+24,299
+125% +$4.37K ﹤0.01% 4495
2024
Q2
$5.93K Buy
+19,385
New +$5.93K ﹤0.01% 4569
2024
Q1
Sell
-43,201
Closed -$7.82K 4610
2023
Q4
$7.82K Sell
43,201
-32,154
-43% -$5.82K ﹤0.01% 4607
2023
Q3
$24.9K Buy
75,355
+22,530
+43% +$7.44K ﹤0.01% 4581
2023
Q2
$77.1K Hold
52,825
﹤0.01% 4408
2023
Q1
$108K Hold
52,825
﹤0.01% 4316
2022
Q4
$122K Sell
52,825
-136
-0.3% -$314 ﹤0.01% 4321
2022
Q3
$161K Hold
52,961
﹤0.01% 4327
2022
Q2
$189K Buy
52,961
+234
+0.4% +$835 ﹤0.01% 4301
2022
Q1
$309K Buy
52,727
+12,920
+32% +$75.7K ﹤0.01% 4168
2021
Q4
$313K Sell
39,807
-117
-0.3% -$920 ﹤0.01% 4280
2021
Q3
$616K Buy
39,924
+1,007
+3% +$15.5K ﹤0.01% 3930
2021
Q2
$872K Buy
38,917
+3,155
+9% +$70.7K ﹤0.01% 3676
2021
Q1
$1.09M Buy
35,762
+7,550
+27% +$230K ﹤0.01% 3514
2020
Q4
$1.03M Buy
28,212
+17,507
+164% +$641K ﹤0.01% 3362
2020
Q3
$81K Hold
10,705
﹤0.01% 3946
2020
Q2
$89K Buy
10,705
+396
+4% +$3.29K ﹤0.01% 3879
2020
Q1
$38K Sell
10,309
-134,061
-93% -$494K ﹤0.01% 3964
2019
Q4
$94K Hold
144,370
﹤0.01% 3980
2019
Q3
$84K Hold
144,370
﹤0.01% 3981
2019
Q2
$127K Buy
144,370
+29,928
+26% +$26.3K ﹤0.01% 3901
2019
Q1
$102K Hold
114,442
﹤0.01% 3891
2018
Q4
$145K Hold
114,442
﹤0.01% 3767
2018
Q3
$581K Buy
114,442
+3,799
+3% +$19.3K ﹤0.01% 3409
2018
Q2
$552K Buy
110,643
+14,322
+15% +$71.5K ﹤0.01% 3401
2018
Q1
$314K Hold
96,321
﹤0.01% 3551
2017
Q4
$408K Hold
96,321
﹤0.01% 3436
2017
Q3
$220K Hold
96,321
﹤0.01% 3643
2017
Q2
$199K Sell
96,321
-28,837
-23% -$59.6K ﹤0.01% 3686
2017
Q1
$257K Buy
125,158
+14,388
+13% +$29.5K ﹤0.01% 3559
2016
Q4
$270K Buy
110,770
+9,561
+9% +$23.3K ﹤0.01% 3500
2016
Q3
$259K Buy
+101,209
New +$259K ﹤0.01% 3503